Publications | USF Parkinson's Disease and Movement Disorders Center

2014

Hauser, RA, D Silver, A Choudhry, E Eyal, and S Isaacson. 2014. “Randomized, Controlled Trial of Rasagiline As an Add-on to Dopamine Agonists in Parkinson’s Disease. Mov Disord 2014;29:1028-34.”. Mov Disord.

Goldman, SM, F Kamel, GW Ross, SA Jewell, C Marras, JA Hoppin, DM Umbach, et al. 2014. “Peptidoglycan Recognition Protein Genes and Risk of Parkinson’s Disease. Mov Disord 2014;29:1171-80.”. Mov Disord.

Hauser, RA, AH Shapira, P Barone, Y Mizuno, O Rascol, M Busse, C Debieuvre, M Fraessdorf, and W Poewe. 2014. “Long-Term Safety and Sustained Efficacy of Extended-Release Pramipexole in Early and Advanced Parkinson’s Disease. Eur J Neurol 2014;21:736-43.”. Eur J Neurol.

Hauser, RA, MF Gordon, Y Mizuno, W Poewe, P Barone, AH Schapira, O Rascol, C Debieuvre, and M Fradorf. 2014. “Minimal Clinically Important Difference in Parkinson’s Disease As Assessed in Pivotal Trials of Pramipexole Extended Release. Parkinsons Dis. 2014; Parkinsons Dis 2014;2014:467131.”. Parkinsons Dis.

Cicchetti, F, S Lacroix, G Cisbani, N Vallieres, M Saint-Pierre, I St-Amour, R Tolouei, J Skepper, RA Hauser, and . 2014. “Mutant Huntingtin Is Present in Neuronal Grafts in Huntington’s Disease Patients. Ann Neurol 2014;76:31-42.”. Ann Neurol.

Investigators, The Parkinson Study Group QE3. 2014. “A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit. JAMA Neurol 2014;71:543-52.”. JAMA Neurol.

Low, PA, D Robertson, S Gilman, H Kaufmann, W Singer, I Biaggioni, R Freeman, et al. 2014. “Efficacy and Safety of Rifampicin for Multiple System Atrophy: A Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Neurol 2014;13:268-75.”. Lancet Neurol.

Kremens, D, RA Hauser, and ER Dorsey. 2014. “An Update on Parkinson’s Disease: Improving Patient Outcomes. Am J Med 2014;127:S3.”. Am J Med.

LeWitt, PA, FJ Huff, RA Hauser, D Chen, D Lissin, K Zomorodi, and KC Cundy. 2014. “Double-Blind Study of the Actively Transported Levodopa Prodrug XP21279 in Parkinson’s Disease. Mov Disord 2014;29:75-82.”. Mov Disord.

Hauser, RA, LA Arthur Hewitt, and S Isaacson. 2014. “Droxidopa in Patients With Neurogenic Orthostatic Hypotension Associated With Parkinson’s Disease (NOH306A). J Parkinsons Dis 2014;4:57-65.”. J Parkinsons Dis.